5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: Physiological role and possible implications in autism spectrum disorders

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Ciranna, Lucia ^a   Catania, Maria Vincenza ^b,c  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Autism spectrum disorders; Fragile X Syndrome; Serotonin; Synaptic function

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL) ETHYL] 1 PYRROLIDINESULFONYL] PHENOL; 5 CARBAMOYLTRYPTAMINE; AMISULPRIDE; AS 19; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; E 55888; E 57431; LP 211; LURASIDONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN CDC42; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG; VORTIOXETINE;

ADAPTIVE BEHAVIOR; AFTERHYPERPOLARIZATION; ANXIETY; AUTISM; BINDING AFFINITY; BODY TEMPERATURE; CATION TRANSPORT; EPILEPSY; EXPLORATORY BEHAVIOR; FRAGILE X SYNDROME; GABAERGIC TRANSMISSION; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY; MOOD DISORDER; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; SYNAPTIC TRANSMISSION; THERMOREGULATION;

EID: 84927550511     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00250     Document Type: Review

References (196)

1. Abbas, A. I., Hedlund, P. B., Huang, X. P., Tran, T. B., Meltzer, H. Y., and Roth, B. L. (2009). Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl) 205, 119-128. doi: 10.1007/s00213-009-1521-8
2. Adriani, W., Travaglini, D., Lacivita, E., Saso, L., Leopoldo, M., and Laviola, G. (2012). Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. Neuropharmacology 62, 833-842. doi: 10.1016/j.neuropharm.2011.09.012
3. Ahern, G. P. (2011). 5-HT and the immune system. Curr. Opin. Pharmacol. 11, 29-33. doi: 10.1016/j.coph.2011.02.004
4. Altamura, C., Dell'Acqua, M. L., Moessner, R., Murphy, D. L., Lesch, K. P., and Persico, A. M. (2007). Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb. Cortex 17, 1394-1401. doi: 10.1093/cercor/bhl051
5. Anderson, G. M., Horne, W. C., Chatterjee, D., and Cohen, D. J. (1990). The hyperserotonemia of autism. Ann. N Y Acad. Sci. 600, 331-340; discussion 341-332. doi: 10.1111/j.1749-6632.1990.tb16893.x
6. Azmitia, E. C., Singh, J. S., and Whitaker-Azmitia, P. M. (2011). Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 60, 1347-1354. doi: 10.1016/j.neuropharm.2011.02.002
7. Bacon, W. L., and Beck, S. G. (2000). 5-Hydroxytryptamine7 receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J. Pharmacol. Exp. Ther. 294, 672-679.
8. Bagdy, G., Kecskemeti, V., Riba, P., and Jakus, R. (2007). Serotonin and epilepsy. J. Neurochem. 100, 857-873. doi: 10.1111/j.1471-4159.2006.04277.x
9. Ballaz, S. J., Akil, H., and Watson, S. J. (2007a). The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neuroscience 149, 192-202. doi: 10.1016/j.neuroscience.2007.07.043
10. Ballaz, S. J., Akil, H., and Watson, S. J. (2007b). Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior. Neuroscience 147, 428-438. doi: 10.1016/j.neuroscience.2007.04.024
11. Bangasser, D. A., and Shors, T. J. (2010). Critical brain circuits at the intersection between stress and learning. Neurosci. Biobehav. Rev. 34, 1223-1233. doi: 10.1016/j.neubiorev.2010.02.002
12. Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A., and Weinshank, R. L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268, 23422-23426.
13. Béïque, J. C., Campbell, B., Perring, P., Hamblin, M. W., Walker, P., Mladenovic, L., et al. (2004a). Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A and 5-HT7 receptors. J. Neurosci. 24, 4807-4817. doi: 10.1523/JNEUROSCI.5113-03.2004
14. Béïque, J. C., Chapin-Penick, E. M., Mladenovic, L., and Andrade, R. (2004b). Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex. J. Physiol. 556, 739-754. doi: 10.1113/jphysiol.2003.051284
15. Belenky, M. A., and Pickard, G. E. (2001). Subcellular distribution of 5-HT(1B) and 5-HT7 receptors in the mouse suprachiasmatic nucleus. J. Comp. Neurol. 432, 371-388. doi: 10.1002/cne.1109
16. Bengtson, C. P., Lee, D. J., and Osborne, P. B. (2004). Opposing electrophysiological actions of 5-HT on noncholinergic and cholinergic neurons in the rat ventral pallidum in vitro. J. Neurophysiol. 92, 433-443. doi: 10.1152/jn.00543.2003
17. Bernardet, M., and Crusio, W. E. (2006). Fmr1 KO mice as a possible model of autistic features. ScientificWorldJournal 6, 1164-1176. doi: 10.1100/tsw.2006.220
18. Bickmeyer, U., Heine, M., Manzke, T., and Richter, D. W. (2002). Differential modulation of I(h) by 5-HT receptors in mouse CA1 hippocampal neurons. Eur. J. Neurosci. 16, 209-218. doi: 10.1046/j.1460-9568.2002.02072.x
19. Birrell, J. M., and Brown, V. J. (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 20, 4320-4324.
20. Bonaventure, P., Kelly, L., Aluisio, L., Shelton, J., Lord, B., Galici, R., et al. (2007). Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 321, 690-698. doi: 10.1124/jpet.107.119404
21. Bonsi, P., Cuomo, D., Ding, J., Sciamanna, G., Ulrich, S., Tscherter, A., et al. (2007). Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT2C, 5-HT6 and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32, 1840-1854. doi: 10.1038/sj.npp.1301294
22. Bourson, A., Kapps, V., Zwingelstein, C., Rudler, A., Boess, F. G., and Sleight, A. J. (1997). Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice. Naunyn Schmiedebergs Arch. Pharmacol. 356, 820-826. doi: 10.1007/PL00005123
23. Boylan, C. B., Blue, M. E., and Hohmann, C. F. (2007). Modeling early cortical serotonergic deficits in autism. Behav. Brain Res. 176, 94-108. doi: 10.1016/j.bbr.2006.08.026
24. Brager, D. H., Akhavan, A. R., and Johnston, D. (2012). Impaired dendritic expression and plasticity of h-channels in the fmr1(-/y) mouse model of fragile X syndrome. Cell Rep. 1, 225-233. doi: 10.1016/j.celrep.2012.02.002
25. Brager, D. H., and Johnston, D. (2007). Plasticity of intrinsic excitability during long-term depression is mediated through mGluR-dependent changes in Ih in hippocampal CA1 pyramidal neurons. J. Neurosci. 27, 13926-13937. doi: 10.1523/JNEUROSCI.3520-07.2007
26. Brager, D. H., and Johnston, D. (2014). Channelopathies and dendritic dysfunction in fragile X syndrome. Brain Res. Bull. 103, 11-17. doi: 10.1016/j.brainresbull.2014.01.002
27. Brenchat, A., Rocasalbas, M., Zamanillo, D., Hamon, M., Vela, J. M., and Romero, L. (2012). Assessment of 5-HT7receptor agonists selectivity using nociceptive and thermoregulation tests in knockout versus wild-type mice. Adv. Pharmacol. Sci. 2012:312041. doi: 10.1155/2012/312041
28. Brenchat, A., Romero, L., Garcia, M., Pujol, M., Burgueno, J., Torrens, A., et al. (2009). 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 141, 239-247. doi: 10.1016/j.pain.2008.11.009
29. Cardenas, C. G., Mar, L. P., Vysokanov, A. V., Arnold, P. B., Cardenas, L. M., Surmeier, D. J., et al. (1999). Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J. Physiol. 518(Pt. 2), 507-523. doi: 10.1111/j.1469-7793.1999.0507p.x
30. Carper, R. A., and Courchesne, E. (2005). Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry 57, 126-133. doi: 10.1016/j.biopsych.2004.11.005
31. Casten, K. S., Gray, A. C., and Burwell, R. D. (2011). Discrimination learning and attentional set formation in a mouse model of fragile X. Behav. Neurosci. 125, 473-479. doi: 10.1037/a0023561
32. Cervantes-Duran, C., Rocha-Gonzalez, H. I., and Granados-Soto, V. (2013). Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats. Neuroscience 252, 396-409. doi: 10.1016/j.neuroscience.2013.08.022
33. Chandana, S. R., Behen, M. E., Juhasz, C., Muzik, O., Rothermel, R. D., Mangner, T. J., et al. (2005). Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. 23, 171-182. doi: 10.1016/j.ijdevneu.2004.08.002
34. Chapin, E. M., and Andrade, R. (2001). A 5-HT7 receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h). J. Pharmacol. Exp. Ther. 297, 403-409.
35. Chen, S., Wang, J., and Siegelbaum, S. A. (2001). Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide. J. Gen. Physiol. 117, 491-504. doi: 10.1085/jgp.117.5.491
36. Chen, L., Yung, K. K., Chan, Y. S., and Yung, W. H. (2008). 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience 151, 439-451. doi: 10.1016/j.neuroscience.2007.11.003
37. Cherubini, E., Rovira, C., Ben-Ari, Y., and Nistri, A. (1990). Effects of kainate on the excitability of rat hippocampal neurones. Epilepsy Res. 5, 18-27. doi: 10.1016/0920-1211(90)90062-Z
38. Cho, I. H., Yoo, H. J., Park, M., Lee, Y. S., and Kim, S. A. (2007). Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res. 1139, 34-41. doi: 10.1016/j.brainres.2007.01.002
39. Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45, 287-295. doi: 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9
40. Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., et al. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol. 42, 666-669. doi: 10.1002/ana.410420420
41. Citrome, L. (2014). Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant-what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int. J. Clin. Pract. 68, 60-82. doi: 10.1111/ijcp.12350
42. Clissold, K. A., Choi, E., and Pratt, W. E. (2013). Serotonin 1A, 1B, and 7 receptors of the rat medial nucleus accumbens differentially regulate feeding, water intake and locomotor activity. Pharmacol. Biochem. Behav. 112, 96-103. doi: 10.1016/j.pbb.2013.10.002
43. Colacicco, G., Welzl, H., Lipp, H. P., and Wurbel, H. (2002). Attentional set-shifting in mice: modification of a rat paradigm and evidence for strain-dependent variation. Behav. Brain Res. 132, 95-102. doi: 10.1016/S0166-4328(01)00391-6
44. Costa, L., Spatuzza, M., D'Antoni, S., Bonaccorso, C. M., Trovato, C., Musumeci, S. A., et al. (2012a). Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of fragile X syndrome. Biol. Psychiatry 72, 924-933. doi: 10.1016/j.biopsych.2012.06.008
45. Costa, L., Trovato, C., Musumeci, S. A., Catania, M. V., and Ciranna, L. (2012b). 5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Hippocampus 22, 790-801. doi: 10.1002/hipo.20940
46. Coutinho, A. M., Sousa, I., Martins, M., Correia, C., Morgadinho, T., Bento, C., et al. (2007). Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum. Genet.121, 243-256. doi: 10.1007/s00439-006-0301-3
47. Cross, S., Kim, S. J., Weiss, L. A., Delahanty, R. J., Sutcliffe, J. S., Leventhal, B. L., et al. (2008). Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 33, 353-360. doi: 10.1038/sj.npp.1301406
48. Devlin, B., Cook, E. H. Jr., Coon, H., Dawson, G., Grigorenko, E. L., McMahon, W., et al. (2005). Autism and the serotonin transporter: the long and short of it. Mol. Psychiatry 10, 1110-1116. doi: 10.1038/sj.mp.4001724
49. Di Pilato, P., Niso, M., Adriani, W., Romano, E., Travaglini, D., Berardi, F., et al. (2014). Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview. Rev. Neurosci. 25, 401-415. doi: 10.1515/revneuro-2014-0009
50. Disterhoft, J. F., Thompson, L. T., Moyer, J. R. Jr., and Mogul, D. J. (1996). Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus. Life Sci. 59, 413-420. doi: 10.1016/0024-3205(96)00320-7
51. Dölen, G., Darvishzadeh, A., Huang, K. W., and Malenka, R. C. (2013). Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 501, 179-184. doi: 10.1038/nature12518
52. Doly, S., Fischer, J., Brisorgueil, M. J., Verge, D., and Conrath, M. (2005). Pre-and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. J. Comp. Neurol. 490, 256-269. doi: 10.1002/cne.20667
53. Dufour-Rainfray, D., Vourc'h, P., Tourlet, S., Guilloteau, D., Chalon, S., and Andres, C. R. (2011). Fetal exposure to teratogens: evidence of genes involved in autism. Neurosci. Biobehav. Rev. 35, 1254-1265. doi: 10.1016/j.neubiorev.2010.12.013
54. Eriksson, T. M., Golkar, A., Ekstrom, J. C., Svenningsson, P., and Ogren, S. O. (2008). 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT1A receptor stimulation on contextual learning in mice. Eur. J. Pharmacol. 596, 107-110. doi: 10.1016/j.ejphar.2008.08.026
55. Eriksson, T. M., Holst, S., Stan, T. L., Hager, T., Sjogren, B., Ogren, S. O., et al. (2012). 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology 63, 1150-1160. doi: 10.1016/j.neuropharm.2012.06.061
56. Errico, M., Crozier, R. A., Plummer, M. R., and Cowen, D. S. (2001). 5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. Neuroscience 102, 361-367. doi: 10.1016/S0306-4522(00)00460-7
57. Fan, Y., Fricker, D., Brager, D. H., Chen, X., Lu, H. C., Chitwood, R. A., et al. (2005). Activity-dependent decrease of excitability in rat hippocampal neurons through increases in Ih. Nat. Neurosci. 8, 1542-1551. doi: 10.1038/nn1568
58. Fernández de Sevilla, D., Fuenzalida, M., Porto Pazos, A. B., and Buño, W. (2007). Selective shunting of the NMDA EPSP component by the slow afterhyperpolarization in rat CA1 pyramidal neurons. J. Neurophysiol. 97, 3242-3255. doi: 10.1152/jn.00422.2006
59. Floresco, S. B., Zhang, Y., and Enomoto, T. (2009). Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav. Brain Res. 204, 396-409. doi: 10.1016/j.bbr.2008.12.001
60. Foxx-Orenstein, A. E., Kuemmerle, J. F., and Grider, J. R. (1996). Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 111, 1281-1290. doi: 10.1053/gast.1996.v111.pm8898642
61. Freret, T., Paizanis, E., Beaudet, G., Gusmao-Montaigne, A., Nee, G., Dauphin, F., et al. (2014). Modulation of 5-HT7receptor: effect on object recognition performances in mice. Psychopharmacology (Berl) 231, 393-400. doi: 10.1007/s00213-013-3247-x
62. Freund, T. F., and Buzsaki, G. (1996). Interneurons of the hippocampus. Hippocampus 6, 347-470. doi: 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I
63. García-Alcocer, G., Segura, L. C., Garcia Pena, M., Martinez-Torres, A., and Miledi, R. (2006). Ontogenetic distribution of 5-HT2C, 5-HT5A and 5-HT7 receptors in the rat hippocampus. Gene Expr. 13, 53-57. doi: 10.3727/000000006783991935
64. Gasbarri, A., Cifariello, A., Pompili, A., and Meneses, A. (2008). Effect of 5-HT7 antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav. Brain Res. 195, 164-170. doi: 10.1016/j.bbr.2007.12.020
65. Gaspar, P., Cases, O., and Maroteaux, L. (2003). The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4, 1002-1012. doi: 10.1038/nrn1256
66. Gellynck, E., Heyninck, K., Andressen, K. W., Haegeman, G., Levy, F. O., Vanhoenacker, P., et al. (2013). The serotonin 5-HT7 receptors: two decades of research. Exp. Brain Res. 230, 555-568. doi: 10.1007/s00221-013-3694-y
67. Geurts, F. J., De Schutter, E., and Timmermans, J. P. (2002). Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7receptor-like immunoreactivity in the rat cerebellum. J. Chem. Neuroanat. 24, 65-74. doi: 10.1016/S0891-0618(02)00020-0
68. Gill, C. H., Soffin, E. M., Hagan, J. J., and Davies, C. H. (2002). 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology 42, 82-92. doi: 10.1016/S0028-3908(01)00149-6
69. Girgis, R. R., Slifstein, M., Xu, X., Frankle, W. G., Anagnostou, E., Wasserman, S., et al. (2011). The 5-HT2 A receptor and serotonin transporter in Asperger's disorder: a PET study with [11C]MDL 100907 and [11 C]DASB. Psychiatry Res. 194, 230-234. doi: 10.1016/j.pscychresns.2011.04.007
70. Glass, J. D., Grossman, G. H., Farnbauch, L., and DiNardo, L. (2003). Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J. Neurosci. 23, 7451-7460.
71. Goaillard, J. M., and Vincent, P. (2002). Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones by activating 5-HT7 receptors. J. Physiol. 541, 453-465. doi: 10.1113/jphysiol.2001.013896
72. Gorinski, N., and Ponimaskin, E. (2013). Palmitoylation of serotonin receptors. Biochem. Soc. Trans. 41, 89-94. doi: 10.1042/BST20120235
73. Graf, M., Jakus, R., Kantor, S., Levay, G., and Bagdy, G. (2004). Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci. Lett. 359, 45-48. doi: 10.1016/j.neulet.2004.01.072
74. Guilloux, J. P., Mendez-David, I., Pehrson, A., Guiard, B. P., Reperant, C., Orvoen, S., et al. (2013). Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology 73, 147-159. doi: 10.1016/j.neuropharm.2013.05.014
75. Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., et al. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48, 492-502. doi: 10.1016/j.neuropharm.2004.11.015
76. Guscott, M. R., Egan, E., Cook, G. P., Stanton, J. A., Beer, M. S., Rosahl, T. W., et al. (2003). The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor. Neuropharmacology 44, 1031-1037. doi: 10.1016/S0028-3908(03)00117-5
77. Hagan, J. J., Price, G. W., Jeffrey, P., Deeks, N. J., Stean, T., Piper, D., et al. (2000). Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist. Br. J. Pharmacol. 130, 539-548.
78. Hall, A. (1998). G proteins and small GTPases: distant relatives keep in touch. Science 280, 2074-2075. doi: 10.1126/science.280.5372.2074
79. Hannon, J., and Hoyer, D. (2008). Molecular biology of 5-HT receptors. Behav. Brain Res. 195, 198-213. doi: 10.1016/j.bbr.2008.03.020
80. Harrington, R. A., Lee, L. C., Crum, R. M., Zimmerman, A. W., and Hertz-Picciotto, I. (2013). Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Autism Res. 6, 149-168. doi: 10.1002/aur.1288
81. Hedlund, P. B. (2009). The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 206, 345-354. doi: 10.1007/s00213-009-1626-0
82. Hedlund, P. B., Danielson, P. E., Thomas, E. A., Slanina, K., Carson, M. J., and Sutcliffe, J. G. (2003). No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc. Natl. Acad. Sci. U S A 100, 1375-1380. doi: 10.1073/pnas.0337340100
83. Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., and Sutcliffe, J. G. (2005). 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol. Psychiatry 58, 831-837. doi: 10.1016/j.biopsych.2005.05.012
84. Hedlund, P. B., Kelly, L., Mazur, C., Lovenberg, T., Sutcliffe, J. G., and Bonaventure, P. (2004). 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur. J. Pharmacol. 487, 125-132. doi: 10.1016/j.ejphar.2004.01.031
85. Hedlund, P. B., Leopoldo, M., Caccia, S., Sarkisyan, G., Fracasso, C., Martelli, G., et al. (2010). LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor. Neurosci. Lett. 481, 12-16. doi: 10.1016/j.neulet.2010.06.036
86. Hedlund, P. B., and Sutcliffe, J. G. (2004). Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol. Sci. 25, 481-486. doi: 10.1016/j.tips.2004.07.002
87. Hedlund, P. B., and Sutcliffe, J. G. (2007). The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci. Lett. 414, 247-251. doi: 10.1016/j.neulet.2006.12.054
88. Hoffman, M. S., and Mitchell, G. S. (2011). Spinal 5-HT7 receptor activation induces long-lasting phrenic motor facilitation. J. Physiol. 589, 1397-1407. doi: 10.1113/jphysiol.2010.201657
89. Huber, K. M., Gallagher, S. M., Warren, S. T., and Bear, M. F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U S A 99, 7746-7750. doi: 10.1073/pnas.122205699
90. Inoue, T., Itoh, S., Wakisaka, S., Ogawa, S., Saito, M., and Morimoto, T. (2002). Involvement of 5-HT7 receptors in serotonergic effects on spike afterpotentials in presumed jaw-closing motoneurons of rats. Brain Res. 954, 202-211. doi: 10.1016/S0006-8993(02)03286-9
91. Ireland, D. R., and Abraham, W. C. (2002). Group I mGluRs increase excitability of hippocampal CA1 pyramidal neurons by a PLC-independent mechanism. J. Neurophysiol. 88, 107-116. doi: 10.1152/jn.00679.2001
92. Ishibashi, T., Horisawa, T., Tokuda, K., Ishiyama, T., Ogasa, M., Tagashira, R., et al. (2010). Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J. Pharmacol. Exp. Ther. 334, 171-181. doi: 10.1124/jpet.110.167346
93. Ishihara, K., Takahashi, N., Komoto, N., Yoshikawa, C., Fukumoto, S., Ide, S., et al. (2013). Serotonergic modulation of neuronal activity in the nucleus accumbens following repeated methamphetamine administration in rats. J. Pharmacol. Sci. 123, 140-146. doi: 10.1254/jphs.13100FP
94. Joëls, M., Pu, Z., Wiegert, O., Oitzl, M. S., and Krugers, H. J. (2006). Learning under stress: how does it work? Trends Cogn. Sci. 10, 152-158. doi: 10.1016/j.tics.2006.02.002
95. Johnson-Farley, N. N., Kertesy, S. B., Dubyak, G. R., and Cowen, D. S. (2005). Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells. J. Neurochem. 92, 72-82. doi: 10.1111/j.1471-4159.2004.02832.x
96. Jung, S., Jones, T. D., Lugo, J. N. Jr., Sheerin, A. H., Miller, J. W., D'Ambrosio, R., et al. (2007). Progressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy. J. Neurosci. 27, 13012-13021. doi: 10.1523/JNEUROSCI.3605-07.2007
97. Jung, S., Warner, L. N., Pitsch, J., Becker, A. J., and Poolos, N. P. (2011). Rapid loss of dendritic HCN channel expression in hippocampal pyramidal neurons following status epilepticus. J. Neurosci. 31, 14291-14295. doi: 10.1523/JNEUROSCI.1148-11.2011
98. Kane, M. J., Angoa-Perez, M., Briggs, D. I., Sykes, C. E., Francescutti, D. M., Rosenberg, D. R., et al. (2012). Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One 7:e48975. doi: 10.1371/journal.pone.0048975
99. Kawahara, F., Saito, H., and Katsuki, H. (1994). Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones. J. Physiol. 478(Pt. 1), 67-73.
100. Kobe, F., Guseva, D., Jensen, T. P., Wirth, A., Renner, U., Hess, D., et al. (2012). 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J. Neurosci. 32, 2915-2930. doi: 10.1523/JNEUROSCI.2765-11.2012
101. Kvachnina, E., Dumuis, A., Wlodarczyk, J., Renner, U., Cochet, M., Richter, D. W., et al. (2009). Constitutive Gs-mediated, but not G12-mediated, activity of the 5-hydroxytryptamine 5-HT7a receptor is modulated by the palmitoylation of its C-terminal domain. Biochim. Biophys. Acta 1793, 1646-1655. doi: 10.1016/j.bbamcr.2009.08.008
102. Kvachnina, E., Liu, G., Dityatev, A., Renner, U., Dumuis, A., Richter, D. W., et al. (2005). 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J. Neurosci. 25, 7821-7830. doi: 10.1523/JNEUROSCI.1790-05.2005
103. Lancaster, B., Hu, H., Ramakers, G. M., and Storm, J. F. (2001). Interaction between synaptic excitation and slow afterhyperpolarization current in rat hippocampal pyramidal cells. J. Physiol. 536, 809-823. doi: 10.1111/j.1469-7793.2001.00809.x
104. Lassig, J. P., Vachirasomtoon, K., Hartzell, K., Leventhal, M., Courchesne, E., Courchesne, R., et al. (1999). Physical mapping of the serotonin 5-HT7 receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12 and testing of linkage disequilibrium between HTR7 and autistic disorder. Am. J. Med. Genet. 88, 472-475. doi: 10.1002/(SICI)1096-8628(19991015)88:5<472::AID-AJMG7>3.0.CO;2-G
105. Leopoldo, M., Lacivita, E., De Giorgio, P., Fracasso, C., Guzzetti, S., Caccia, S., et al. (2008). Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7receptor activity. Part III. J. Med. Chem. 51, 5813-5822. doi: 10.1021/jm800615e
106. Lesch, K. P., and Waider, J. (2012). Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76, 175-191. doi: 10.1016/j.neuron.2012.09.013
107. Lin, S. L., Johnson-Farley, N. N., Lubinsky, D. R., and Cowen, D. S. (2003). Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J. Neurochem. 87, 1076-1085. doi: 10.1046/j.1471-4159.2003.02076.x
108. Liu, J., Akay, T., Hedlund, P. B., Pearson, K. G., and Jordan, L. M. (2009). Spinal 5-HT7 receptors are critical for alternating activity during locomotion: in vitro neonatal and in vivo adult studies using 5-HT7 receptor knockout mice. J. Neurophysiol. 102, 337-348. doi: 10.1152/jn.91239.2008
109. Logue, S. F., and Gould, T. J. (2014). The neural and genetic basis of executive function: attention, cognitive flexibility and response inhibition. Pharmacol. Biochem. Behav. 123C, 45-54. doi: 10.1016/j.pbb.2013.08.007
110. Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., et al. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11, 449-458. doi: 10.1016/0896-6273(93)90149-L
111. Luscher, C., and Huber, K. M. (2010). Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65, 445-459. doi: 10.1016/j.neuron.2010.01.016
112. Magee, J. C. (1998). Dendritic hyperpolarization-activated currents modify the integrative properties of hippocampal CA1 pyramidal neurons. J. Neurosci. 18, 7613-7624.
113. Magee, J. C. (1999). Dendritic Ih normalizes temporal summation in hippocampal CA1 neurons. Nat. Neurosci. 2, 848. doi: 10.1038/12229
114. Manuel-Apolinar, L., and Meneses, A. (2004). 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behav. Brain Res. 148, 179-184. doi: 10.1016/S0166-4328(03)00186-4
115. Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., et al. (2000). Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry 33, 165-168. doi: 10.1055/s-2000-7588
116. Martin-Cora, F. J., and Pazos, A. (2004). Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. Br. J. Pharmacol. 141, 92-104. doi: 10.1038/sj.bjp.0705576
117. Matthys, A., Haegeman, G., Van Craenenbroeck, K., and Vanhoenacker, P. (2011). Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol. Neurobiol. 43, 228-253. doi: 10.1007/s12035-011-8175-3
118. McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., et al. (1998). Effects of diagnosis, race and puberty on platelet serotonin levels in autism and mental retardation. J. Am. Acad. Child Adolesc. Psychiatry 37, 767-776. doi: 10.1097/00004583-199807000-00017
119. McCormick, D. A., and Pape, H. C. (1990). Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurones. J. Physiol. 431, 291-318.
120. McNamara, I. M., Borella, A. W., Bialowas, L. A., and Whitaker-Azmitia, P. M. (2008). Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res. 1189, 203-214. doi: 10.1016/j.brainres.2007.10.063
121. Meneses, A. (2013). 5-HT systems: emergent targets for memory formation and memory alterations. Rev. Neurosci. 24, 629-664. doi: 10.1515/revneuro-2013-0026
122. Millan, M. J., Marin, P., Bockaert, J., and la Cour, C. M. (2008). Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol. Sci. 29, 454-464. doi: 10.1016/j.tips.2008.06.007
123. Mnie-Filali, O., Faure, C., Lambas-Senas, L., El Mansari, M., Belblidia, H., Gondard, E., et al. (2011). Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 36, 1275-1288. doi: 10.1038/npp.2011.13
124. Monsma, F. J. Jr., Shen, Y., Ward, R. P., Hamblin, M. W., and Sibley, D. R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43, 320-327.
125. Monti, J. M., and Jantos, H. (2014). The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness. Rev. Neurosci. 25, 429-437. doi: 10.1515/revneuro-2014-0016
126. Monti, J. M., Leopoldo, M., and Jantos, H. (2008). The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav. Brain Res. 191, 184-189. doi: 10.1016/j.bbr.2008.03.025
127. Monti, J. M., Leopoldo, M., and Jantos, H. (2014). Systemic administration and local microinjection into the central nervous system of the 5-HT7 receptor agonist LP-211 modify the sleep-wake cycle in the rat. Behav. Brain Res. 259, 321-329. doi: 10.1016/j.bbr.2013.11.030
128. Monti, J. M., Leopoldo, M., Jantos, H., and Lagos, P. (2012). Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep. Pharmacol. Biochem. Behav. 102, 373-380. doi: 10.1016/j.pbb.2012.05.012
129. Moyer, J. R. Jr., Thompson, L. T., and Disterhoft, J. F. (1996). Trace eyeblink conditioning increases CA1 excitability in a transient and learning-specific manner. J. Neurosci. 16, 5536-5546.
130. Mozzachiodi, R., and Byrne, J. H. (2010). More than synaptic plasticity: role of nonsynaptic plasticity in learning and memory. Trends Neurosci. 33, 17-26. doi: 10.1016/j.tins.2009.10.001.
131. Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., et al. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution and behavioral correlates. J. Am. Acad. Child Adolesc. Psychiatry 43, 491-499. doi: 10.1097/00004583-200404000-00016
132. Muneoka, K. T., and Takigawa, M. (2003). 5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive 'stigmoid body'-like structure in developing rat brains. Int. J. Dev. Neurosci. 21, 133-143. doi: 10.1016/S0736-5748(03)00029-7
133. Murphy, D. G., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., et al. (2006). Cortical serotonin 5-HT2Areceptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am. J. Psychiatry 163, 934-936. doi: 10.1176/appi.ajp.163.5.934
134. Naumenko, V. S., Kondaurova, E. M., and Popova, N. K. (2011). On the role of brain 5-HT7 receptor in the mechanism of hypothermia: comparison with hypothermia mediated via 5-HT1A and 5-HT3 receptor. Neuropharmacology 61, 1360-1365. doi: 10.1016/j.neuropharm.2011.08.022
135. Neumaier, J. F., Sexton, T. J., Yracheta, J., Diaz, A. M., and Brownfield, M. (2001). Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization and agonist stimulated cFos expression. J. Chem. Neuroanat. 21, 63-73. doi: 10.1016/S0891-0618(00)00092-2
136. Nichols, D. E., and Nichols, C. D. (2008). Serotonin receptors. Chem. Rev. 108, 1614-1641. doi: 10.1021/cr078224o
137. Nikiforuk, A. (2012). Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behav. Brain Res. 226, 118-123. doi: 10.1016/j.bbr.2011.09.006
138. Nikiforuk, A., Kos, T., Fijal, K., Holuj, M., Rafa, D., and Popik, P. (2013). Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS One8:e66695. doi: 10.1371/journal.pone.0066695
139. Nikiforuk, A., and Popik, P. (2013). Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Behav. Brain Res. 248, 136-140. doi: 10.1016/j.bbr.2013.04.008
140. Norum, J. H., Hart, K., and Levy, F. O. (2003). Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a). J. Biol. Chem. 278, 3098-3104. doi: 10.1074/jbc.M206237200
141. Oblak, A., Gibbs, T. T., and Blatt, G. J. (2013). Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism. Autism Res. 6, 571-583. doi: 10.1002/aur.1317
142. Oh, M. M., McKay, B. M., Power, J. M., and Disterhoft, J. F. (2009). Learning-related postburst afterhyperpolarization reduction in CA1 pyramidal neurons is mediated by protein kinase A. Proc. Natl. Acad. Sci. U S A 106, 1620-1625. doi: 10.1073/pnas.0807708106
143. Otmakhova, N. A., Lewey, J., Asrican, B., and Lisman, J. E. (2005). Inhibition of perforant path input to the CA1 region by serotonin and noradrenaline. J. Neurophysiol. 94, 1413-1422. doi: 10.1152/jn.00217.2005
144. Perez-Garcia, G. S., and Meneses, A. (2005). Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Behav. Brain Res. 163, 136-140. doi: 10.1016/j.bbr.2005.04.014
145. Pericic, D., and Svob Strac, D. (2007). The role of 5-HT7 receptors in the control of seizures. Brain Res. 1141, 48-55. doi: 10.1016/j.brainres.2007.01.019
146. Pietropaolo, S., Guilleminot, A., Martin, B., D'Amato, F. R., and Crusio, W. E. (2011). Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice. PLoS One 6:e17073. doi: 10.1371/journal.pone.0017073
147. Piven, J., Tsai, G. C., Nehme, E., Coyle, J. T., Chase, G. A., and Folstein, S. E. (1991). Platelet serotonin, a possible marker for familial autism. J. Autism Dev. Disord. 21, 51-59. doi: 10.1007/BF02206997
148. Pytliak, M., Vargova, V., Mechirova, V., and Felsoci, M. (2011). Serotonin receptors-from molecular biology to clinical applications. Physiol. Res. 60, 15-25.
149. Ramoz, N., Reichert, J. G., Corwin, T. E., Smith, C. J., Silverman, J. M., Hollander, E., et al. (2006). Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol. Psychiatry 60, 186-191. doi: 10.1016/j.biopsych.2006.01.009
150. Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., et al. (2012). Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J. Cell Sci. 125, 2486-2499. doi: 10.1242/jcs.101337
151. Roberts, A. J., and Hedlund, P. B. (2012). The 5-HT7 receptor in learning and memory. Hippocampus 22, 762-771. doi: 10.1002/hipo.20938
152. Roberts, A. J., Krucker, T., Levy, C. L., Slanina, K. A., Sutcliffe, J. G., and Hedlund, P. B. (2004a). Mice lacking 5-HT receptors show specific impairments in contextual learning. Eur. J. Neurosci. 19, 1913-1922. doi: 10.1111/j.1460-9568.2004.03288.x
153. Roberts, C., Thomas, D. R., Bate, S. T., and Kew, J. N. (2004b). GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 46, 935-941. doi: 10.1016/j.neuropharm.2004.01.010
154. Romano, E., Ruocco, L. A., Nativio, P., Lacivita, E., Ajmone-Cat, M. A., Boatto, G., et al. (2014). Modulatory effects following subchronic stimulation of brain 5-HT7-R system in mice and rats. Rev. Neurosci. 25, 383-400. doi: 10.1515/revneuro-2014-0007
155. Roth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., and Monsma, F. J. Jr. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther.268, 1403-1410.
156. Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M., et al. (1993). Molecular cloning, characterization and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U S A 90, 8547-8551. doi: 10.1073/pnas.90.18.8547
157. Ruocco, L. A., Romano, E., Treno, C., Lacivita, E., Claudio, A., Gironi-Carnevale, U. A., et al. (2013). Emotional and risk seeking behavior after prepuberal subchronic or adult acute stimulation of 5-HT7-Rs in naples high excitability rats. Synapse 68, 159-167. doi: 10.1002/syn.21724
158. Sah, P. (1996). Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends Neurosci. 19, 150-154. doi: 10.1016/S0166-2236(96)80026-9
159. Sarkisyan, G., and Hedlund, P. B. (2009). The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav. Brain Res. 202, 26-31. doi: 10.1016/j.bbr.2009.03.011
160. Sarkisyan, G., Roberts, A. J., and Hedlund, P. B. (2010). The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior. Behav. Brain Res. 209, 99-108. doi: 10.1016/j.bbr.2010.01.022
161. Schain, R. J., and Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 58, 315-320.
162. Shen, Y., Monsma, F. J. Jr., Metcalf, M. A., Jose, P. A., Hamblin, M. W., and Sibley, D. R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268, 18200-18204.
163. Shimizu, M., Nishida, A., Zensho, H., Miyata, M., and Yamawaki, S. (1998). Agonist-induced desensitization of adenylyl cyclase activity mediated by 5-hydroxytryptamine7 receptors in rat frontocortical astrocytes. Brain Res.784, 57-62.
164. Smith, B. N., Sollars, P. J., Dudek, F. E., and Pickard, G. E. (2001). Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. J. Biol. Rhythms 16, 25-38. doi: 10.1177/074873040101600104
165. Sodhi, M. S., and Sanders-Bush, E. (2004). Serotonin and brain development. Int. Rev. Neurobiol. 59, 111-174. doi: 10.1016/S0074-7742(04)59006-2
166. Speranza, L., Chambery, A., Di Domenico, M., Crispino, M., Severino, V., Volpicelli, F., et al. (2013). The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways. Neuropharmacology 67, 155-167. doi: 10.1016/j.neuropharm.2012.10.026
167. Spooren, W., Lindemann, L., Ghosh, A., and Santarelli, L. (2012). Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends Pharmacol. Sci. 33, 669-684. doi: 10.1016/j.tips.2012.09.004
168. Sugita, S., Shen, K. Z., and North, R. A. (1992). 5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala. Neuron 8, 199-203. doi: 10.1016/0896-6273(92)90121-S
169. Surges, R., Kukley, M., Brewster, A., Ruschenschmidt, C., Schramm, J., Baram, T. Z., et al. (2012). Hyperpolarization-activated cation current Ih of dentate gyrus granule cells is upregulated in human and rat temporal lobe epilepsy. Biochem. Biophys. Res. Commun. 420, 156-160. doi: 10.1016/j.bbrc.2012.02.133
170. Sutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., et al. (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 77, 265-279. doi: 10.1086/432648
171. Teitler, M., and Klein, M. T. (2012). A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture and in vivo. Pharmacol. Ther. 133, 205-217. doi: 10.1016/j.pharmthera.2011.10.007
172. Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., et al. (2003). SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br. J. Pharmacol. 139, 705-714. doi: 10.1038/sj.bjp.0705290
173. Tokarski, K., Kusek, M., and Hess, G. (2011). 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J. Physiol. Pharmacol. 62, 535-540.
174. Tokarski, K., Kusek, M., and Hess, G. (2012a). Repeated blockade of 5-HT7 receptors depresses glutamatergic transmission in the rat frontal cortex. J. Physiol. Pharmacol. 63, 173-177.
175. Tokarski, K., Zahorodna, A., Bobula, B., and Hess, G. (2003). 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res. 993, 230-234. doi: 10.1016/j.brainres.2003.09.015
176. Tokarski, K., Zelek-Molik, A., Duszynska, B., Satala, G., Bobula, B., Kusek, M., et al. (2012b). Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus. Pharmacol. Rep. 64, 256-265. doi: 10.1016/S1734-1140(12)70763-6
177. Tombaugh, G. C., Rowe, W. B., and Rose, G. M. (2005). The slow afterhyperpolarization in hippocampal CA1 neurons covaries with spatial learning ability in aged Fisher 344 rats. J. Neurosci. 25, 2609-2616. doi: 10.1523/JNEUROSCI.5023-04.2005
178. Varnäs, K., Thomas, D. R., Tupala, E., Tiihonen, J., and Hall, H. (2004). Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. Neurosci. Lett. 367, 313-316. doi: 10.1016/j.neulet.2004.06.025
179. Vasefi, M. S., Kruk, J. S., Heikkila, J. J., and Beazely, M. A. (2013). 5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFβ receptor dependent. J. Neurochem. 125, 26-36. doi: 10.1111/jnc.12157
180. Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., et al. (2012). Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc. Natl. Acad. Sci. U S A 109, 5469-5474. doi: 10.1073/pnas.1112345109
181. Viguier, F., Michot, B., Hamon, M., and Bourgoin, S. (2013). Multiple roles of serotonin in pain control mechanisms-implications of 5-HT7 and other 5-HT receptor types. Eur. J. Pharmacol. 716, 8-16. doi: 10.1016/j.ejphar.2013.01.074
182. Viguier, F., Michot, B., Kayser, V., Bernard, J. F., Vela, J. M., Hamon, M., et al. (2012). GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain. Neuropharmacology 63, 1093-1106. doi: 10.1016/j.neuropharm.2012.07.023
183. Wassink, T. H., Hazlett, H. C., Epping, E. A., Arndt, S., Dager, S. R., Schellenberg, G. D., et al. (2007). Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch. Gen. Psychiatry 64, 709-717. doi: 10.1001/archpsyc.64.6.709
184. Wesolowska, A., Nikiforuk, A., and Stachowicz, K. (2006a). Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur. J. Pharmacol.553, 185-190. doi: 10.1016/j.ejphar.2006.09.064
185. Wesolowska, A., Nikiforuk, A., Stachowicz, K., and Tatarczynska, E. (2006b). Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51, 578-586. doi: 10.1016/j.neuropharm.2006.04.017
186. Whitaker-Azmitia, P. M. (2005). Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int. J. Dev. Neurosci. 23, 75-83. doi: 10.1016/j.ijdevneu.2004.07.022
187. Witkin, J. M., Baez, M., Yu, J., Barton, M. E., and Shannon, H. E. (2007). Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds. Epilepsy Res. 75, 39-45. doi: 10.1016/j.eplepsyres.2007.03.017
188. Witteveen, J. S., Middelman, A., van Hulten, J. A., Martens, G. J., Homberg, J. R., and Kolk, S. M. (2013). Lack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation. Front. Cell. Neurosci. 7:143. doi: 10.3389/fncel.2013.00143
189. Woehler, A., and Ponimaskin, E. G. (2009). G protein-mediated signaling: same receptor, multiple effectors. Curr. Mol. Pharmacol. 2, 237-248. doi: 10.2174/1874467210902030237
190. Wolfensteller, U., and Ruge, H. (2012). Frontostriatal mechanisms in instruction-based learning as a hallmark of flexible goal-directed behavior. Front. Psychol. 3:192. doi: 10.3389/fpsyg.2012.00192
191. Woo, Y. S., Wang, H. R., and Bahk, W. M. (2013). Lurasidone as a potential therapy for bipolar disorder. Neuropsychiatr. Dis. Treat. 9, 1521-1529. doi: 10.2147/NDT.S51910
192. Wu, W. W., Chan, C. S., and Disterhoft, J. F. (2004). Slow afterhyperpolarization governs the development of NMDA receptor-dependent afterdepolarization in CA1 pyramidal neurons during synaptic stimulation. J. Neurophysiol.92, 2346-2356. doi: 10.1152/jn.00977.2003
193. Yanarates, O., Dogrul, A., Yildirim, V., Sahin, A., Sizlan, A., Seyrek, M., et al. (2010). Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology 112, 696-710. doi: 10.1097/ALN.0b013e3181cd7920
194. Yang, E. J., Han, S. K., and Park, S. J. (2014). Functional expression of 5-HT7 receptor on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice. Brain Res. 1543, 73-82. doi: 10.1016/j.brainres.2013.10.041
195. Yang, Z., Liu, X., Yin, Y., Sun, S., and Deng, X. (2012). Involvement of 5-HT7 receptors in the pathogenesis of temporal lobe epilepsy. Eur. J. Pharmacol. 685, 52-58. doi: 10.1016/j.ejphar.2012.04.011
196. Zhang, Z. W. (2003). Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development. J. Neurosci. 23, 3373-3384.